MedTrace Logo

Immunity After COVID-19 Vaccination

NCT04924855 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-06-14

No results posted yet for this study

Summary

The purpose of the research is to evaluate kinetic after vaccination to the COVID-19 coronavirus by measurements of specific and neutralizant antibodies for spike antigenic sequences .

This work will allow us to follow the efficacy and tolerance of the vaccine over a year, to evaluate the antibody profile, their kinetics, the fraction of neutralising antibodies and will also allow us to understand the attitudes to be taken to ensure the best protection for our staff

Conditions

  • Tunis Military Hospital Staff Vaccinated Against Covid 19

Interventions

OTHER

Blood sampling (4 per year)

Blood sampling (4 per year)

Sponsors & Collaborators

  • General Administration of Military Health, Tunisia

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-31
Primary Completion
2022-07-01
Completion
2022-08-01

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04924855 on ClinicalTrials.gov